CDGCX
Price
$15.20
Change
+$0.14 (+0.93%)
Updated
Oct 17 closing price
Net Assets
61.09M
VIVIX
Price
$72.41
Change
+$0.36 (+0.50%)
Updated
Oct 17 closing price
Net Assets
207.8B
Interact to see
Advertisement

CDGCX vs VIVIX

Header iconCDGCX vs VIVIX Comparison
Open Charts CDGCX vs VIVIXBanner chart's image
Crawford Large Cap Dividend C
Price$15.20
Change+$0.14 (+0.93%)
VolumeN/A
Net Assets61.09M
Vanguard Value Index I
Price$72.41
Change+$0.36 (+0.50%)
VolumeN/A
Net Assets207.8B
CDGCX vs VIVIX Comparison Chart in %
View a ticker or compare two or three
VS
CDGCX vs. VIVIX commentary
Oct 20, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CDGCX is a Buy and VIVIX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VIVIX has more cash in the bank: 208B vs. CDGCX (61.1M). VIVIX pays higher dividends than CDGCX: VIVIX (2.09) vs CDGCX (0.25). CDGCX was incepted earlier than VIVIX: CDGCX (22 years) vs VIVIX (27 years). CDGCX (1.97) is less costly to investors than VIVIX (0.04). CDGCX is a more actively managed with annual turnover of: 15.00 vs. VIVIX (9.00). CDGCX has a lower initial minimum investment than VIVIX: CDGCX (2500) vs VIVIX (5000000). VIVIX annual gain was more profitable for investors over the last year : 4.64 vs. CDGCX (-0.31). VIVIX return over 5 years is better than : 71.78 vs. CDGCX (26.21).
CDGCXVIVIXCDGCX / VIVIX
Total Expense Ratio1.970.044,925%
Annual Report Gross Expense Ratio1.970.044,925%
Fund Existence22 years27 years-
Gain YTD9.8279.748101%
Front LoadN/AN/A-
Min. Initial Investment250050000000%
Min. Initial Investment IRAN/AN/A-
Net Assets61.1M208B0%
Annual Yield % from dividends0.252.0912%
Returns for 1 year-0.314.64-7%
Returns for 3 years26.7942.9862%
Returns for 5 years26.2171.7837%
Returns for 10 years41.79129.4032%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
STRA80.481.29
+1.63%
Strategic Education
PNNT6.430.01
+0.16%
Pennant Investment Corp
AFJKU11.25N/A
N/A
Aimei Health Technology Co Ltd
WCC213.78-4.62
-2.12%
Wesco International
HOWL1.60-0.07
-4.19%
Werewolf Therapeutics